For research use only. Not for human consumption.
Tesamorelin is a synthetic 44-amino-acid peptide analog of Growth Hormone-Releasing Hormone (GHRH).
Price range: 56,00 € through 94,00 €
Tesamorelin is a synthetic 44-amino-acid peptide analog of Growth Hormone-Releasing Hormone (GHRH). It features a trans-3-hexenoic acid modification at the N-terminus, which enhances its enzymatic stability and resistance to rapid cleavage by dipeptidyl peptidase-4 (DPP-4), allowing it to effectively stimulate GHRH receptors in the anterior pituitary.
Visceral Adipose Reduction: Studied extensively for its ability to target and mobilize deep visceral adipose tissue (VAT) without causing significant loss of subcutaneous fat.
IGF-1 Modulation & GH Secretion: Evaluated for inducing natural pulsatile endogeneous growth hormone release, subsequently elevating circulating IGF-1 levels.
Metabolic & Lipid Profiles: Researched in clinical models for improving triglyceride clearance, hepatic lipid density, and overall body composition markers.
To provide a stable GHRH analog reference compound for investigating targeted visceral lipolysis, pituitary GHRH receptor dynamics, and systemic metabolic parameters in laboratory research.
| Property | Details |
| Product Name | Tesamorelin |
| Product Category | Growth Hormone Secretagogues & GHRH Analogs |
| Compound Type | Synthetic N-Modified 44-Amino-Acid GHRH Analog |
| Primary Goal | Visceral fat mobilization, endogenous GH pulse stimulation, and lipid profile study |
| Form | Lyophilized powder (vial) |
| Storage | Store lyophilized powder at 2°C to 8°C (refrigerated) or -20°C for long-term storage. Protect from direct light. |
| Intended Use | Laboratory Research Only |
| Dosage | 10MG, 20MG |
|---|
Explore similar research-grade peptides, selected to complement your research needs.
By proceeding you affirm the statements above are true. This site uses cookies to remember your verification status. Privacy Policy.
